期刊： DRUGS OF THE FUTURE, 2021; 46 (7)
BioCon China 2021 was held in Shanghai, China, April 22-23, 2021, focusing on the discovery and design, process development and optimization of biolog......
期刊： DRUGS OF THE FUTURE, 2020; 45 (7)
Engineering science and technology are important driving forces in the development of society, and engineering fronts are important guidelines for the......
期刊： DRUGS OF THE FUTURE, 2020; 45 (4)
The world of scientific research presents a sprawling, ever-changing landscape. The ability to identify where the action is and, in particular, to tra......
期刊： DRUGS OF THE FUTURE, 2022; 47 (6)
Pediatric blood disorders represent a category of noncancerous diseases typically affecting infants and children. They negatively impact and impair a ......
期刊： DRUGS OF THE FUTURE, 2022; 47 (6)
Immunotherapy is a broad-spectrum antitumor strategy that exerts therapeutic effects on various types of tumors. In recent decades, there has been rap......
期刊： DRUGS OF THE FUTURE, 2022; 47 (12)
Breast cancer represents the highest number of new cases of cancer globally. Approximately 80% of patients diagnosed with breast cancer have hormone r......
期刊： DRUGS OF THE FUTURE, 2022; 47 (1)
Gliomas are the most frequent malignant tumors of the central nervous system, with varied outcomes and an unmet need of highly efficacious treatments.......
期刊： DRUGS OF THE FUTURE, 2022; 47 (9)
In the past 2 decades, the understanding of cancer pathogenesis at the molecular level has helped therapy-targeting specific oncogenic drivers to be a......
期刊： DRUGS OF THE FUTURE, 2022; 47 (7)
Taletrectinib (DS-6051b, AB-106, IBI-344) is an efficacious and highly selective inhibitor of proto-oncogene tyrosine-protein kinase ROS (ROS1) and ne......
期刊： DRUGS OF THE FUTURE, 2022; 47 (11)
Colorectal cancer (CRC) is one of the cancers with high mor-bidity and mortality worldwide, and its treatment and prog-nosis have undergone tremendous......
期刊： DRUGS OF THE FUTURE, 2017; 42 (10)
Eptinezumab (ALD-403) is a genetically engineered, humanized, desialylated anti-calcitonin gene-related peptide (CGRP) IgG1 monoclonal antibody that s......
